Kentsis Research Group

@KentsisResearch

Exploring biology and developing new therapies for children and adults with refractory cancers . All views are our own.

New York City
Vrijeme pridruživanja: travanj 2013.

Tweetovi

Blokirali ste korisnika/cu @KentsisResearch

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @KentsisResearch

  1. Prikvačeni tweet
    2. velj

    Are you interested in oncogenic transposons, chromatin, and DNA nucleases? We are looking for ambitious post-doctoral research fellows: please join us! It's an exciting project!

    Poništi
  2. proslijedio/la je Tweet
    prije 21 sat

    5 days until TeamHopp’s 1st NYC ride & we have raised > $250K for rare cancer research ⁦⁩⁩. Funding brilliant minds to solve rare cancer; all pediatric cancers are rare & need our support. ⁦⁩ ⁦⁩ ⁦

    Poništi
  3. proslijedio/la je Tweet
    3. velj

    "The stress & overwhelming crushing defeat of these bills that would come in every week —it had an effect on our quality of life." After keeping it secret for over a decade, I went public in 2017 on how had affected me & my late husband

    Poništi
  4. proslijedio/la je Tweet
    1. velj

    Authors of disputed “uncanny” 2019-nCoV preprint to voluntarily withdraw preprint: "It was not our intention to feed into the conspiracy theories...we appreciate the criticisms...and will get back with a revised version”

    Poništi
  5. proslijedio/la je Tweet
    3. velj

    Help and others in help kids in Mexico with cancer, through the Global Cancer Program, bringing an adapted UCSF500 molecular sequencing platform for resource-constrained settings!

    Poništi
  6. proslijedio/la je Tweet
    3. velj

    Condolences to Phil Leder's family and worldwide colleagues. He made groundbreaking contributions on the genetics of cancer and aging. This is a sad day for science.

    Poništi
  7. proslijedio/la je Tweet
    2. velj

    Wow: Google's "Meena" chatbot was trained on a full TPUv3 pod (2048 TPU cores) for **30 full days** - That's more than $1,400,000 of compute time to train this chatbot model. (! 100+ petaflops of sustained compute !)

    Poništi
  8. proslijedio/la je Tweet
    16. sij

    New Ph.D.s in cancer biology, DNA repair, epigenetics, genomics, tumor immunology, protein translation - consider joining me ! Probe the interface of your expertise and transposable element biology. So much we don’t know!

    Poništi
  9. proslijedio/la je Tweet
    2. velj

    When the nucleus realizes that mitochondrial DNA is in trouble. A cool story from the awesome Marco in my lab...

    Prikaži ovu nit
    Poništi
  10. proslijedio/la je Tweet
    1. velj

    Congratulations ! An inspirational journey... Go middle-easterners!

    Poništi
  11. 31. sij

    Concept by teamwork by Danmeng Luo and Ben Herzberg with and Masa Uni keeping careful scientific records

    Prikaži ovu nit
    Poništi
  12. 31. sij

    High-throughput proximity labeling proteomics

    Prikaži ovu nit
    Poništi
  13. proslijedio/la je Tweet
    31. sij

    Exciting stuff from - Auxin-induced Brg1 degradation and the regulation of Polycomb distribution over the genome

    Poništi
  14. proslijedio/la je Tweet
    30. sij
    Poništi
  15. proslijedio/la je Tweet
    30. sij

    Very happy to see this published. Terrific work by Hannah and critical input from our collaborators , George Vassiliou, Lars Bullinger and Jerry McGeehan . Molecules are in clinical trials!

    Poništi
  16. proslijedio/la je Tweet

    Tazemetostat is approved for treatment of rare epithelioid sarcoma treatment. Dr. Charles Roberts’ 2010 paper helped lay groundwork for this approval, suggesting an EZH2 inhibitor could be used to treat cancers with SMARCB1/INI1 deficiencies.

    Poništi
  17. proslijedio/la je Tweet
    29. sij

    Nothing soothes the frustration of a mass spec being out of order for a month like doing Western blotting. 5 attempts to (kind of) get detection of one phospho-protein, let alone its quantification. Now I have a straight answer to those objecting that is time consuming

    Poništi
  18. proslijedio/la je Tweet
    28. sij

    Exciting new instrument development work from Brian Erickson of the and : Parallel notched gas-phase enrichment for improved proteome identification and quantitation with fast spectral acquisition rates

    Poništi
  19. proslijedio/la je Tweet
    27. sij
    Poništi
  20. 27. sij
    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·